Levothyroxine Sodium
Product Images NDC 70934-326

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 70934-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 25 (70934 266 30 Rev A 02 19)

Label 25 (70934 266 30   Rev A 02 19)
This is a medication information for Levothyroxine Sodium Tablets, USP with a strength of 25mcg. The package contains 30 tablets and is available only through a prescription. The remaining text seems to be distorted or unreadable.*
FDA Label Image

Label 50 (70934 273 30 Rev A 02 19)

Label 50 (70934 273 30   Rev A 02 19)
This appears to be a description of a medication called Levothyroxine Sodium in tablet form with a strength of 50 mcg (0.050mg). The National Drug Code (NDC) is listed as 70934-273-30 and the package contains 20 tablets (05wy 20 T 3). The remaining text is not clear or readable.*
FDA Label Image

Label 112 (70934 274 30 Rev A 02 19)

Label 112 (70934 274 30   Rev A 02 19)
This is a description of Levothyroxine Sodium Tablets, USP, with NDC number 70934-274-30 and a strength of 112 mcg, or 0.112mg. The package contains 30 tablets. There is information regarding an "Uty s ek 59 12," which is unclear but may be related to product expiration or manufacture. There is also mention of "i Cheme" and "Loty st ek, 517 by Theea," which are unclear and may have been misread during .*
FDA Label Image

Label 75 (70934 292 30 Rev A 02 19)

Label 75 (70934 292 30   Rev A 02 19)
This is a medication label for Levothyroxine Sodium Tablets, USP with a strength of 75 mcg (0.075mg). The package contains 30 tablets and is identified by the National Drug Code (NDC) number 70934-292-30. The remaining text is not-readable and may include unintended characters.*
FDA Label Image

Label 100 (70934 308 30 Rev A 03 19)

FDA Label Image

Label 150 (70934 314 30 Rev A 03 19)

Label 150 (70934 314 30   Rev A 03 19)
The text includes the NDC code, medication name, strength, and dosage form for Levothyroxine Sodium Tablets. The rest of the text appears to be illegible and not useful for providing any additional information.*
FDA Label Image

Label 88 (70934 326 30 Rev A 04 19)

Label 88 (70934 326 30   Rev A 04 19)
This appears to be the packaging information for Levothyroxine Sodium tablets, USP in 88 mcg strength with 30 tablets in a bottle. The National Drug Code (NDC) of this medication is 70934-326-30. Unfortunately, the remaining text is not legible, likely due to a poor quality scan.*
FDA Label Image

Chemical Structure (Levothyroxine Sodium Tablet Usp Jsp 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.